Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 25, 2009
View Archived Issues
Clinical development reported for SparVax, a recombinant protective antigen anthrax vaccine
Read More
AstraZeneca researchers describe new Axl and c-Met inhibitors
Read More
Recent Protia patent imparts novel antipsychotic deuterium-enriched olanzapine analogues
Read More
Solvay reports a novel sildenafil prodrug for erectile dysfunction in recent patent
Read More
ChemoCentryx discloses new chemokine CCR2 receptor antagonists for RA and other conditions
Read More
New Nav1.7 sodium channel blockers presented by AstraZeneca
Read More
Lilly patents novel farnesoid X receptor agonists for the treatment of lipoprotein disorders
Read More
Novel soluble epoxide hydrolase inhibitors disclosed by Merck & Co.
Read More
Basilea provides update on Zevtera regulatory delays
Read More
GW reports encouraging results in randomized withdrawal Sativex study
Read More
BioDiem and Nobilon commence phase I clinical trials for LAIV
Read More
Primary objective of STRIDE-PD Stalevo study was not achieved
Read More
Antibody fragment ESBA-105 enters phase IIa studies for uveitis
Read More
Camurus initiates phase I/II CAM-2038 trial for opiate addiction
Read More
CPEX initiates phase II Nasulin trial in type 2 diabetes
Read More
Xencor and CSL sign antibody optimization collaboration including access to XmAb
Read More
Opsona signs collaboration agreement with CSL in infectious diseases and oncology
Read More
Ambrx and Merck Serono sign agreement to develop and commercialize ARX-424 for MS
Read More
ImmunoCellular identifies new peptides to broaden applicability of ICT-121 cancer vaccine
Read More
Kapidex delayed-release capsules available for the treatment of GERD
Read More
Drug scaffold targeting choline-binding proteins created for pneumococcal infections
Read More
Orexin receptor-2 agonism inhibits diet-induced obesity in mice
Read More
NeuroSearch reports phase II proof-of-concept results for NS-2359 in depression
Read More
Phase III budesonide trial in children with asthma did not meet primary endpoints
Read More
Pfizer discontinues development of two phase III compounds
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe